Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.
Eto M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S; Japan RCC Trialist Collaborative Group (JRTCG) investigators.
Eto M, et al. Among authors: matsubara a.
BMC Cancer. 2015 Oct 9;15:667. doi: 10.1186/s12885-015-1675-1.
BMC Cancer. 2015.
PMID: 26452347
Free PMC article.
Clinical Trial.